COMPLETE METABOLIC RESPONSE TO POLATUZUMAB VEDOTIN AND GLOFITAMAB IN PRIMARY REFRACTORY DOUBLE-EXPRESSOR DIFFUSE LARGE B-CELL LYMPHOMA WITH EXTENSIVE EXTRANODAL DISEASE AND ECOG 4

EHA Library, AYESHA ALALEELI, 4210386

PROGNOSTIC IMPACT OF BASELINE WEIGHT LOSS ON SURVIVAL OUTCOMES IN DIFFUSE LARGE B-CELL LYMPHOMA:A SINGLE-CENTER STUDY IN TUNISIA

EHA Library, daami mayssa, 4210387

SUCCESSFUL USE OF CAR-T WITH BRIDGE RADIOTHERAPY IN A PATIENT WITH EARLY RELAPSE OF REFRACTORY DLBCL AFTER ALLO-HSCT. CLINICAL CASE.

EHA Library, Katsiaryna Zharkova, 4210388

DISTINCT CLINICAL FEATURES BUT COMPARABLE SURVIVAL BETWEEN PEDIATRIC AND ADULT PATIENTS WITH SYSTEMIC ANAPLASTIC LARGE CELL LYMPHOMA

EHA Library, Sun-Hye Ko, 4210399

PROGNOSTIC FACTORS AND REAL-WORLD OUTCOMES OF ADULT T-CELL LEUKEMIA/LYMPHOMA IN AN HTLV-1 ENDEMIC REGION: A 10-YEAR SINGLE-CENTER STUDY

EHA Library, Leila Cysique-Foinlan, 4210402

EFFICACY AND SAFETY OF LIPOSOMAL MITOXANTRONE–CONTAINING REGIMENS IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED ADVANCED ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA

EHA Library, jifeng jiang, 4210403

FRONTLINE MGZL: HIGH EVENT RATES WITH HL-LIKE AND AGGRESSIVE B-CELL REGIMENS; EARLY FEASIBILITY OF NIVOLUMAB-BASED, TRANSPLANT-SPARING R-DA-EPOCH + DACARBAZINE

EHA Library, Runisa Abdurashidova, 4210405

CLINICAL AND PATHOLOGICAL HETEROGENEITY WITH DISTINCT GENOMIC FEATURES IMPACTS PROGNOSIS IN MONOMORPHIC EPITHELIOTROPIC INTESTINAL T-CELL LYMPHOMA: A MULTICENTER RETROSPECTIVE COHORT STUDY FROM CHINA

EHA Library, Ji-nuo Wang, 4210409

OVERALL SURVIVAL DIFFERENCES IN ELDERLY PATIENTS WITH ANGIOIMMUNOBLASTIC T CELL LYMPHOMA TREATED AT ACADEMIC VS COMMUNITY CANCER PROGRAMS

EHA Library, Henry Idrobo, 4210413

TREATMENT OF MEDIASTINAL GRAY ZONE LYMPHOMA WITH HIGH-DOSE THERAPY AND IMMUNE CHECK-POINT INHIBITORS AFTER RELAPSE ON FIRST LINE CHEMO-IMMUNOTHERAPY: SURVIVAL UPDATE

EHA Library, Maher Salamoon, 4210418

DESIGN, SYNTHESIS AND PHARMACOLOGICAL EVALUATION OF 3H-SPIRO[BENZOFURAN-2,4'-PIPERIDINE] IRAK4 INHIBITORS FOR THE TREATMENT OF DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Hua Xie, 4210421

MINE REGIMEN COMBINED WITH TARGETED AGENTS IN RELAPSED/REFRACTORY ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA: A PRELIMINARY EXPLORATORY RETROSPECTIVE STUDY INTEGRATED WITH NEXT-GENERATION SEQUENCING

EHA Library, Yuelu Guo, 4210424

HIGH-DOSE VITAMIN C SUPPRESSES JAK-STAT/IFN-Γ SIGNALING AND IMPROVES SURVIVAL IN HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS

EHA Library, Kai Qing, 4210426

GOLIDOCITINIB-BASED COMBINATION THERAPY AS FIRST-LINE TREATMENT FOR PTCL: A SINGLE-CENTER RETROSPECTIVE ANALYSIS (JACKPOT55)

EHA Library, Wenyu Li, 4210428

TREATMENT OUTCOMES AND RELAPSE DYNAMICS IN BURKITT LYMPHOMA: REAL-WORLD DATA FROM A NATIONAL LATIN AMERICAN REFERENCE CENTER

EHA Library, Amaya Llorente-Chávez, 4210429

BRENTUXIMAB VEDOTIN IN COMBINATION WITH CHEMOTHERAPY FOR  PEDIATRIC RELAPSED/REFRACTORY ALK+ALCL PATIENTS IN CHINA

EHA Library, Yonghong Zhang, 4210430

PRELIMINARY RESULTS OF INDUCTION THERAPY USING MITOXANTRONE LIPOSOMES,ETOPOSIDE,AND METHYLPREDNISOLONE FOR LYMPHOMA-ASSOCIATED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS

EHA Library, Lu Zhang, 4210432

REAL-WORLD OUTCOMES OF MITOXANTRONE HYDROCHLORIDE LIPOSOME COMBINED WITH ETOPOSIDE, METHYLPREDNISOLONE IN THE TREATMENT OF LYMPHOMA-ASSOCIATED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS

EHA Library, Huo Tan, 4210433

ANALYSIS OF TREATMENT OUTCOMES AND PROGNOSIS IN 52 CASES OF ANAPLASTIC LARGE CELL LYMPHOMA WITH LYMPHOMA KINASE MUTATION

EHA Library, wen zhang, 4210434

GENOMIC SIGNATURES GUIDED COMBINATION THERAPY OF TAZEMETOSTAT PLUS LINPERLISIB OR GOLIDOCITINIB IN RELAPSED AND REFRACTORY PERIPHERAL T-CELL LYMPHOMA PATIENTS

EHA Library, Shu Cheng, 4210438

CORRELATION BETWEEN THE CD4+/CD8+ RATIO AND IMMUNOPHENOTYPIC PARAMETERS IN MYCOSIS FUNGOIDES AND SÉZARY SYNDROME: A MULTICENTER RETROSPECTIVE ANALYSIS

EHA Library, Hadhami Touaiti, 4210442

EFFICACY AND SAFETY OF BRENTUXIMAB VEDOTIN WITH CHIDAMIDE IN CD30-POSITIVE CUTANEOUS T-CELL LYMPHOMA: A MULTICENTER, OPEN-LABEL, SINGLE-COHORT STUDY PROTOCOL IN PROGRESS

EHA Library, Qian Wang, 4210443

SPATIAL AND TEMPORAL HETEROGENEITY OF CD30 EXPRESSION IN T-CELL LYMPHOMAS

EHA Library, Leonie Oevel, 4210444

ALK-POSITIVE VERSUS ALK-NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA: CLINICAL FEATURES, PROGNOSTIC FACTORS, AND OUTCOMES IN MEXICAN POPULATION

EHA Library, Amaya Llorente-Chávez, 4210447

THE EPIDEMIOLOGICAL BURDEN OF HEMATOLOGICAL NEOPLASMS AMONG PEDIATRIC POPULATION IN SPAIN, 2009-2018

EHA Library, Aina Romaguera, 4210449

REAL-WORLD TOXICITY AND DOSE-LEVEL DYNAMICS OF R-DA-EPOCH IN AGGRESSIVE B-CELL LYMPHOMAS

EHA Library, Marta Rodríguez-Quecedo, 4210450

PRESENTATION AND CLINICAL OUTCOMES IN ANAPLASTIC LARGE CELL LYMPHOMA PATIENTS DIAGNOSED IN SASKATCHEWAN, CANADA: A POPULATION‐BASED COHORT STUDY

EHA Library, Brooke Roeges, 4210451

GOLIDOCITINIB、MITOXANTRONE HYDROCHLORIDE LIPOSOME、CHIDAMIDE AND PREDNISONE (GO-MCP) IN RELAPSED/REFRACTORY PERIPHERAL T-CELL LYMPHOMA:A REAL-WORLD RETROSPECTIVE STUDY

EHA Library, Zheng Ge, 4210452

TUMOR MICROENVIRONMENT–ASSOCIATED GENE EXPRESSION AND IMMUNE INFILTRATION PATTERNS IN DIFFUSE LARGE B-CELL AND HODGKIN LYMPHOMAS PATIENTS

EHA Library, Magdalena Witkowska, 4210453

BRENTUXIMAB VEDOTIN COMBINED WITH CHIDAMIDEIN AND MITOXANTRONE HYDROCHLORIDE LIPOSOME OR GOLIDOCITINIB IN RELAPSED/REFRACTORY CD30-POSITIVE CUTANEOUS T-CELL LYMPHOMA: A REAL-WORLD STUDY DESIGN

EHA Library, Qian Wang, 4210456

BURKITT'S LYMPHOMA IN CHILDREN: A REPORT OF 35 CASES - EXPERIENCE OF THE PEDIATRIC CLINICAL HEMATOLOGY DEPARTMENT OF AZIZA OTHMANA HOSPITAL.

EHA Library, ons Dagdoug, 4210457

EPIDEMIOLOGICAL AND CLINICAL CHARACTERISTICS OF BURKITT LYMPHOMA: A SINGLE-CENTERRETROSPECTIVE STUDY

EHA Library, Rym Cherni, 4210460

T-CELL ACTIVATION AND ANTITUMOR ACTIVITY OF MOSUNETUZUMAB PLUS LENALIDOMIDE IN HUMANIZED MICE AND FOLLICULAR LYMPHOMA PATIENT-DERIVED T-CELLS

EHA Library, Hayato Mizuta, 4210463

EXPRESSION OF THE HLA CLASS I ANTIGEN PRESENTATION PATHWAY ASSOCIATES WITH SENSITIVITY TO PD-L1 BLOCKADE IN TREATMENT-NAÏVE DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)

EHA Library, Kate Manos, 4210464

POLATUZUMAB VEDOTIN ENHANCES T-CELL INFILTRATION INTO TUMORS AND DEMONSTRATES COMBINATORIAL EFFICACY WITH CD20-CD3 BISPECIFIC ANTIBODY IN A SYNGENEIC B-CELL MALIGNANCY MOUSE MODEL

EHA Library, Mayu Tomita, 4210466

MULTIMODAL SINGLE CELL SPATIAL TRANSCRIPTOMIC AND PROTEOMIC ANALYSIS DETECTS CAR-T CELLS WITHIN THE LBCL TUMOUR MICROENVIRONMENT FOLLOWING CD19 CAR-T IMMUNOTHERAPY

EHA Library, Helen Cashman, 4210467

GENE EXPRESSION PROFILING OF EBV-POSITIVE VERSUS EBV-NEGATIVE HIV-ASSOCIATED DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Aleix Mendez-Lopez, 4210470

UNLEASHING BCL2 INHIBITION IN FOLLICULAR LYMPHOMA WITH ZANUBRUTINIB: A TRANSLATIONAL TRIAL WITH MECHANISTIC INSIGHTS FROM SINGLE CELL ANALYSIS

EHA Library, Y. Lynn Wang, 4210471

ELEVATED DOUBLE-NEGATIVE T CELLS AND ALTERED B-CELL MEMORY COMPARTMENTS AS IMMUNOPHENOTYPIC BIOMARKERS OF UNDERLYING INBORN ERRORS OF IMMUNITY IN YOUNG PATIENTS WITH LYMPHOPROLIFERATIVE DISORDERS

EHA Library, Eleonora Gambineri, 4210474

ALK KINASE ACTIVATION USING PTPN1/PTPN2 DEGRADER-DRUGS AS TWO-PRONGED ANTI-LYMPHOMA STRATEGY IN ANAPLASTIC LARGE CELL LYMPHOMA

EHA Library, Nicola Mora, 4210475

COMBINATION OF GOLIDOCITINIB WITH CHIDAMIDE FOR PERIPHERAL T-CELL LYMPHOMA: POSSIBLE MECHANISMS AND THERAPEUTIC POTENTIAL IN INHIBITING TUMOR PROLIFERATION AND MODULATING THE IMMUNE MICROENVIRONMENT

EHA Library, Li LI, 4210476

SELINEXOR IN COMBINATION WITH R-GDP FOR RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS WITH TP53 ALTERATIONS: A PROSPECTIVE, SINGLE-ARM, PHASE II STUDY

EHA Library, Ying Fang, 4210478

EMERGING ROLE OF SAMHD1 IN ANTI-TUMOR IMMUNE RESPONSES AND SENSITIVITY TO CHEMOTHERAPY IN CLASSICAL HODGKIN LYMPHOMA

EHA Library, Dora Trogrlic, 4210479

HBB-CTCF-FEN1 AXIS MEDIATES PLATINUM RESISTANCE VIA ACTIVATING DNA DAMAGE REPAIR IN DLBCL

EHA Library, xutao guo, 4210484

CHARACTERIZATION OF IMMUNE BIOMARKERS IN THE PERIPHERAL BLOOD IN CORRELATION WITH TOTAL METABOLIC TUMOR VOLUME IN CLASSICAL HODGKIN LYMPHOMA.

EHA Library, Zaid Mansur, 4210489

CD70-TARGETED IMMUNO-PET/CT FOR DETECTING HETEROGENEOUS CD70 EXPRESSION IN LYMPHOMAS: A PILOT CLINICAL STUDY

EHA Library, Tingting Liu, 4210490

PREVALENCE OF SARCOPENIA AND ITS PROGNOSTIC IMPACT ON SURVIVAL IN DIFFUSE LARGE B-CELL LYMPHOMA:A SINGLE-CENTER STUDY FROMTUNISIA

EHA Library, daami mayssa, 4210389

INTENSIVE THERAPY FOR HIGH-RISK B-CELL LYMPHOMAS. A 10-YEAR SINGLE-CENTER EXPERIENCE

EHA Library, Nelli Gabeeva, 4210390

EFFICACY AND PROGNOSTIC ANALYSIS OF FIRST - LINE BTK INHIBITOR THERAPY IN MANTLE CELL LYMPHOMA: A REAL - WORLD MULTICENTER STUDY

EHA Library, Haiwen Huang, 4210391

AZACITIDINE-CHEMOTHERAPY COMBINATIONS FOR T-CELL LYMPHOMAS

EHA Library, Arvid Cederlund, 4210392

INTEGRATING CLINICAL, GENETIC, AND IMAGING PARAMETERS FOR RISK STRATIFICATION IN ADULT BURKITT’S LYMPHOMA: A SINGLE-CENTER REAL-WORLD COHORT STUDY

EHA Library, Ji-nuo Wang, 4210393

REAL-WORLD OUTCOMES OF BELINOSTAT IN RELAPSED REFRACTORY T-CELL LYMPHOMAS: A REPORT FROM THE LYMPHOMA STUDY GROUP OF  TURKISH SOCIETY OF HEMATOLOGY

EHA Library, Elif Birtaş Ateşoğlu, 4210394

REAL-WORLD EFFECTIVENESS AND SAFETY OF TOTAL SKIN ELECTRON BEAM THERAPY IN ADVANCED CUTANEOUS T-CELL LYMPHOMAS: A REAL-WORLD SINGLE-CENTER EXPERIENCE.

EHA Library, Carmen Amorós Pérez, 4210395

EXTRANODAL SITES AND NUMBER AS PROGNOSTIC INDICATORS IN ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA WITH FOCUS ON LIVER, SPLEEN, AND BONE MARROW

EHA Library, Mengmeng Dong, 4210397

IMPACT OF FACILITY TYPE ON OUTCOMES FOR ELDERLY PATIENTS (≥75) WITH BURKITT LYMPHOMA: REAL-WORLD DATA OF ACADEMIC VS. COMMUNITY CANCER PROGRAMS

EHA Library, Luis Felipe Rubalcava Lara, 4210398

GOLIDOCITINIB AND LIPOSOMAL MITOXANTRONE FOR RELAPSED/REFRACTORY PERIPHERAL T-CELL LYMPHOMA: PRELIMINARY SAFETY AND EFFICACY FROM A MULTI-CENTER RETROSPECTIVE STUDY

EHA Library, Qingqing Cai, 4210401

SERUM INTERLEUKIN-6 (IL-6) MONITORING IN IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE: IMPORTANT VALUE IN PATIENTS RECEIVING NON-ANTI-IL-6 THERAPY

EHA Library, Zi-han Yang, 4210404

PRELIMINARY EFFICACY AND SAFETY OF THE PMOED REGIMEN AS INDUCTION THERAPY FOR NEWLY DIAGNOSED NATURAL KILLER/T-CELL LYMPHOMA

EHA Library, Li Gao, 4210406

SAFETY AND EFFECTIVENESS OF BRENTUXIMAB VEDOTIN IN CHINESE PATIENTS WITH CD30-POSITIVE NON-NODAL PERIPHERAL T-CELL LYMPHOMAS: A SUBGROUP ANALYSIS OF BRAVE STUDY

EHA Library, Shu Cheng, 4210407

ASSOCIATION BETWEEN SHORT DIAGNOSIS-TO-TREATMENT INTERVAL AND POOR PROGNOSIS IN NEWLY DIAGNOSED AGGRESSIVE ADULT T-CELL LEUKEMIA/LYMPHOMA (ATL)

EHA Library, Kikuaki Yoshida, 4210408

LATE HIV PRESENTATION IN PATIENTS WITH HIV-ASSOCIATED LYMPHOMA: DIAGNOSTIC AND MANAGEMENT CHALLENGES – A MULTICENTER RETROSPECTIVE STUDY BY THE POLISH LYMPHOMA RESEARCH GROUP

EHA Library, Agnieszka Giza, 4210410

FRONTLINE BV-CHP VERSUS CHOP/CHOEP IN PERIPHERAL T-CELL LYMPHOMA: A MULTICENTER REAL-WORLD COHORT STUDY

EHA Library, Shlomzion Aumann, 4210411

SAFETY AND EFFICACY OF GOLIDOCITINIB IN COMBINATION WITH AZACITIDINE AND CHIDAMIDE FOR THE TREATMENT OF PERIPHERAL T-CELL LYMPHOMA: AN OPEN-LABEL, SINGLE-ARM STUDY

EHA Library, Shu Cheng, 4210412

A MULTICENTER, OPEN-LABEL, PHASE 3, RANDOMIZED TRIAL OF DUVELISIB VS INVESTIGATOR’S CHOICE (GEMCITABINE OR BENDAMUSTINE) IN RELAPSED/REFRACTORY NODAL T-CELL LYMPHOMA WITH T-FOLLICULAR HELPER PHENOTYPE

EHA Library, Kate Cwynarski, 4210414

REAL-WORLD EFFICACY AND PROGNOSTIC LANDSCAPE OF BRENTUXIMAB VEDOTIN (BV) IN DIVERSE LYMPHOMA SUBTYPES: A MULTICENTER STUDY

EHA Library, Xian Li, 4210417

THE EFFICACY AND SAFETY OF THE IVD/EM REGIMEN FOR PATIENTS WITH T-CELL LYMPHOBLASTIC LYMPHOMA/LEUKEMIA

EHA Library, Yue Song, 4210419

TRIAL IN PROGRESS: A PHASE 3, MULTIREGIONAL, OPEN-LABEL, RANDOMIZED STUDY OF TIRABRUTINIB VS RITUXIMAB AND TEMOZOLOMIDE IN RELAPSED/REFRACTORY PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (IGNITE)

EHA Library, Lakshmi Nayak, 4210420

REAL-WORLD EFFICACY AND SAFETY ANALYSIS OF MITOXANTRONE HYDROCHLORIDE LIPOSOME IN THE TREATMENT OF PERIPHERAL T-CELL LYMPHOMA

EHA Library, Xiaoqing Li, 4210422

CELL CYCLE–FOCUSED CHEMICAL SCREEN REVEALS MITOTIC KINASE INHIBITORS THAT ENHANCE THE EFFICACY OF A CD30-TARGETED ANTIBODY–DRUG CONJUGATE

EHA Library, Yuto Mori, 4210425

DO BORTEZOMIB-CONTAINING THERAPIES IMPROVE THE OUTCOMES IN PLASMABLASTIC LYMPHOMA?

EHA Library, Guray Saydam, 4210427

RUXOLITINIB PENETRATES BLOOD BRAIN BARRIER AND REDUCES THE CYTOKINE STORM IN PATIENTS WITH HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS

EHA Library, Kai Qing, 4210431

IMPACT OF MODERN TREATMENT OPTIONS IN PATIENTS WITH HIV-ASSOCIATED LYMPHOMAS

EHA Library, Nathalie Lehnen, 4210435

AGGRESSIVE PRIMARY GASTROINTESTINAL LYMPHOMAS: ARE WE MANAGING THEM OPTIMALLY?

EHA Library, Anaghim Aloui, 4210436

IDENTIFYING KNOWLEDGE GAPS IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA THROUGH ONLINE CONTINUING MEDICAL EDUCATION

EHA Library, Sarah Elizabeth Bomba, 4210437

FOLLICULAR MYCOSIS FUNGOIDES: CLINICAL CHARACTERISTICS, TREATMENT PATTERNS AND SURVIVAL OUTCOMES IN A CHINESE SINGLE-CENTRE COHORT OF 19 PATIENTS

EHA Library, Jiawen Luo, 4210439

CANADIAN PROVINCE PRESENTATION AND TREATMENT RELATED OUTCOMES OF ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA: A RETROSPECTIVE CHART REVIEW

EHA Library, Montana Mellor, 4210441

CD30-INDEPENDENT EFFICACY OF BRENTUXIMAB VEDOTIN IN ADVANCED CUTANEOUS T-CELL LYMPHOMA: INSIGHTS FROM A REAL-WORLD COHORT

EHA Library, Mo Cheng, 4210445

SQLE UPREGULATION AND ALTERED CHOLESTEROL HOMEOSTASIS SIGNATURE IN CRIZOTINIB-RESISTANT ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA

EHA Library, wenyu shi, 4210446

SEQUENTIAL POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS (PTLDS) WITH DISTINCT HISTOPATHOLOGICAL FEATURES: COMPREHENSIVE CLINICAL AND MOLECULAR ANALYSIS

EHA Library, Marketa Rackova, 4210448

EPIDEMIOLOGICAL, CLINICAL, BIOLOGICAL CHARACTERISTICS AND THERAPEUTIC OUTCOMES OF BURKITT LYMPHOMA: A SINGLE-CENTER STUDY IN TUNISIA

EHA Library, daami mayssa, 4210454

PRIMARY GASTROINTESTINAL LYMPHOMAS: A CLINICOPATHOLOGIC ANALYSIS OF A SINGLE-CENTER COHORT

EHA Library, Wafa Sakli, 4210455

BURKITT LYMPHOMA: A RETROSPECTIVE STUDY OF 51 CASES

EHA Library, Nizar Dahmaoui, 4210458

FOLLICULAR LYMPHOMA: REAL-WORLD DATA ON PRESENTATION, MANAGEMENT, AND SURVIVAL FROM A MOROCCAN TERTIARY CARE CENTER

EHA Library, Zineb Afroukh, 4210459

THERAPEUTIC OUTCOMES IN ADULTS WITH BURKITT LYMPHOMA TREATED WITH THE LMB-02PROTOCOL: A SINGLE-CENTER EXPERIENCE

EHA Library, Rym Cherni, 4210461

SINGLE-CELL TRANSCRIPTOMIC PROFILING OF PEDIATRIC T-LYMPHOBLASTIC LYMPHOMA REVEALS RELAPSE-SPECIFIC PROGRAMS AND CANDIDATE THERAPEUTIC TARGETS

EHA Library, Vlada Tuliavko, 4210462

NEUTROPHIL–DLBCL CROSSTALK REVEALS AN ANTI-TUMOR ROLE FOR CATHELICIDIN

EHA Library, Nataliia Pavliuchenko, 4210465

TRANSFERRIN RECEPTOR 1-TARGETED NANOCARRIER FOR METHOTREXATE DELIVERY ENHANCES BLOOD-BRAIN BARRIER PENETRATION AND THERAPEUTIC EFFICACY IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA

EHA Library, Qing Yang, 4210468

HIGH-DEFINITION SPATIAL TRANSCRIPTOMICS AND SINGLE-CELL ATLAS OF PRIMARY BREAST DLBCL REVEAL FUNCTIONAL COMPARTMENTALIZATION AND SPECIALIZED IMMUNE

EHA Library, Chaowei Zhang, 4210469

THE EPSTEIN-BARR VIRUS LMP1 PROMOTES B CELL LYMPHOMA BY ENHANCING AICDA VIA AP-1 SIGNALLING

EHA Library, Lungile Mapekula, 4210472

GERMLINE NFKB1 VARIANT IS INDICATIVE OF INFERIOR OVERALL AND POST-RELAPSE SURVIVAL OUTCOMES IN PATIENTS WITH MANTLE CELL LYMPHOMA: ANALYSIS OF 459 CZECH PATIENTS REGISTRY COHORT

EHA Library, Jana Karolová, 4210473

TARC & MDC DEPLETE PERIPHERAL ACTIVATED T CELLS AND T REGULATORY CELLS IN CLASSIC HODGKIN LYMPHOMA: A GHSG NIVAHL TRIAL ANALYSIS

EHA Library, Terézia Kolenová, 4210477

PROFILING CLONAL DYNAMICS AND T CELL STATES IN PATIENTS WITH B-CELL LYMPHOMA TREATED WITH COMMERCIAL CD20XCD3 T-CELL ENGAGERS

EHA Library, Gottfried von Keudell, 4210480

TOWARDS A MOUSE MODEL FOR LYMPHOPROLIFERATION INDUCED BY IL4R MUTATION IN PMBL

EHA Library, Sarah Bailly, 4210481

MYC REARRANGEMENT IN PEDIATRIC NON-BURKITT MATURE B-CELL LYMPHOMA: PROGNOSTIC IMPACT AND ASSOCIATED CLINICAL AND MOLECULAR FEATURES

EHA Library, Qinlong Zheng, 4210482

GENETICALLY FAITHFUL, TRANSCRIPTIONALLY TRANSFORMED: MICROENVIRONMENT-DRIVEN DIVERGENCE IN MATCHED LBCL PRECLINICAL MODELS

EHA Library, Dmitry Manakov, 4210483

DIVERGENT GENOMIC LANDSCAPES IN DLBCL: NOVEL NFKBIE ALTERATIONS AND TP53 DOMINANCE IN INDIAN PATIENTS CHALLENGE WESTERN FRAMEWORKS

EHA Library, Rahul Bhargav, 4210485

THE INDOLEDIONE DERIVATIVE 211H SELECTIVELY TARGETS TP53 R175H-MUTANT AGGRESSIVE B-CELL LYMPHOMA VIA INDUCTION OF APOPTOSIS AND FERROPTOSIS

EHA Library, Wenhua Wang, 4210486

A PEPTIDE TARGETING OUTER MEMBRANE PROTEIN OF B-CELL LYMPHOMA  EXHIBITS TARGETED THERAPY POTENTIAL AND APPLICATION

EHA Library, Haiwen Huang, 4210487

DECIPHERING THE SPATIAL ARCHITECTURE OF LYMPHOMA

EHA Library, Maria Fanouria Chatziaslani, 4210488

LONG-READ SEQUENCING IMPROVES THE CYTOGENOMIC DIAGNOSIS OF NON-HODGKIN LYMPHOMA AND REVEALS ADDITIONAL INFORMATION

EHA Library, Amber Verhasselt, 4210491